???????? HIGH HOPES Wall Street has high hopes for these 5 cannabis stocks Despite the lack of federal cannabis reform in the US and a long list of other challenges facing the industry, analysts see long-term potential in cannabis stocks, reports Insider.
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What’s Next?”
AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark for C$20m (£11.6m).
Enough has been written about the historic year in Canadian cannabis.
